Back to Trades
Sell4
Moderna, Inc.
MRNA
Total Value
$1.2M
Net $703.3K sold
Sales
$703.3K
1 transaction
Company Information
- Company Name
- Moderna, Inc.
- Ticker Symbol
- MRNA
- CIK
- 0001682852
Insider Information
- Name
- AFEYAN NOUBAR
- Role
- Insider
- Location
- CAMBRIDGE, MA
Filing Details
- Filing Date
- Dec 15, 2025
- Transaction Date
- Dec 11, 2025
- Accession Number
- 0001193125-25-318567
- Form Type
- 4
- Net Trading Amount
- -$703.3K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Dec 11, 2025 | Common Stock | 23,853 | $10.90 | Exercise | $260.0K |
| Dec 11, 2025 | Common Stock | 23,853 | $29.48 | Sale | $703.3K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Dec 11, 2025 | Derivative | 23,853 | $10.90 | Exercise | $260.0K |
Footnotes
- (F1)On December 11, 2025, Flagship Pioneering, Inc. ("Flagship Pioneering") exercised options to purchase 23,853 shares of the Issuer's Common Stock at $10.90 per share, which options were set to expire on February 23, 2026.
- (F2)The securities are held directly by Flagship Pioneering. Flagship Pioneering is contractually obligated to transfer and/or remit the proceeds of any sale of shares to Flagship Fund IV, L.P. ("Flagship Fund IV"). The reporting person is the CEO and sole stockholder of Flagship Pioneering and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- (F3)The securities are held directly by Flagship Fund IV. Flagship Ventures Fund IV General Partner LLC ("Flagship Fund IV GP") is the general partner of Flagship Fund IV. The reporting person is the sole manager of Flagship Fund IV GP and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- (F4)The securities are held directly by Flagship Ventures Fund IV-Rx, L.P. ("Flagship Fund IV-Rx"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- (F5)The options were fully vested and exercisable.